Aequus Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company that focuses on developing and commercializing high-quality, cost-effective medical treatments. With its headquarters in Vancouver, British Columbia, the company seeks to enhance patient care by making complex therapeutic solutions more accessible. Aequus specializes in delivering strategic transdermal products and extended-release oral products primarily targeting the central nervous system and the ophthalmology sector. By collaborating with industry partners, Aequus aims to leverage innovative delivery systems and optimize drug formulations to improve patient compliance. The company is instrumental in addressing unmet medical needs in therapeutic areas such as neurology and ophthalmology, thereby playing a crucial role in the pharmaceutical market by aligning with healthcare providers to bring impactful solutions to the forefront. Aequus Pharmaceuticals’ approach positions it as a significant player in the Canadian and global pharmaceutical landscape, reinforcing its commitment to fostering advancements in patient health management systems.